Malignant Lymphomas of the Genitourinary Tract: a Single Center Study in Western India

Authors

  • Vinamrata Soni Department of Oncopathology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India
  • Jahnavi Gandhi Department of Oncopathology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India
  • Sneha Kakoty Department of Oncopathology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India
  • Ashini Hemal Shah Department of Oncopathology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India
  • Priti Trivedi Department of Oncopathology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India

Keywords:

Diffuse large B-cell lymphoma, Extranodal lymphoma, Genitourinary lymphoma

Abstract

Background: Genitourinary (GU) lymphomas are rare, accounting for <5% of extranodal lymphomas (ENL). We analyzed 43 cases of GU lymphomas in both sexes. To determine the epidemiology, clinicopathological, and immunohistochemical features of GU lymphomas.

Materials and Methods: We conducted a retrospective analysis of archival cases from the Department of Oncopathology over a 7-year period (January 2018 to December 2024). Slides and blocks were retrieved and reviewed.

Results: A total of 43 cases of GU lymphomas were obtained. 32 out of 43 cases (74.4%) were primary, and the rest 11 cases (25.6%) were secondary. The mean age at diagnosis was 47 years. The male: female ratio was 1.2:1. Testis (34.9%) followed by ovaries (32.6%) were the most frequently involved sites. Other less commonly involved sites were kidney, urinary bladder, penis, prostate, and vagina. Diffuse large B-cell lymphoma (DLBCL, 65.1%) was found to be the most common subtype. Neither T-cell lymphoma nor Hodgkin lymphoma cases were identified. HIV seropositivity was noted in 2 ovarian Burkitt lymphoma cases. Bone marrow involvement occurred in 4 cases. Mean follow-up duration was 11.9 months, with two patient deaths.

Conclusion: GU lymphomas, though extremely rare, have a variety of subtypes. Hence, one should be cognizant of the possibility of lymphoma arising in these sites to avoid misdiagnosis. Use of immunohistochemistry and other molecular techniques further assists in its accurate diagnosis.

References

1.Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet.2017;390:298-310

2.Economopoulos T, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Tsatalas C, et al. Multifocal extranodal non- Hodgkin lymphoma: A clinicopathologic study of 37 cases in Greece a H cooperative oncology G study. O 2005;10:734-8.

3.Schniederjan, S., Osunkoya, A. Lymphoid neoplasms of the urinary tract and male genital organs: a clinicopathological study of 40 cases. 2009; Mod Pathol 22, 1057–1065.

4.Krol ADG, le Cessie S, SnijderS, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal Non Hodgkin lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003;14:131-139.

5.Taheri MR, Dighe MK, Kolokythas O, True LD, Brusg WH. Multifaceted genitourinary lymphoma. Curr Probl Diagn Radiol 2008;37:80-93

6.Ferreri, A. J. M., & Dolcetti, R. (2007). "Microorganisms in the pathogenesis of lymphoma: A review of the evidence." The Lancet Oncology, 8(6), 505-514

7.Al-Abbadi MA, Hattab EM, Tarawneh M, Orazi A, Ulbright TM. Primary testicular and paratesticular lymphoma: a retrospective clinicopathological study of 34 cases with emphasis on differential diagnosis. Arch Pathol Lab Med 2007; 131:1040-1046.

8.Bates AW, Norton AJ, Baithun SI. Malignant lymphoma of the urinary bladder. A clinicopathological study of 11 cases. J Clin Pathol 2000;53:458-461

9.Bostwick DG, Iczkowski KA, Amin MB, Discigil G, Osborne B. Malignant lymphoma involving the prostate: report of 62 cases. Cancer 1998;83:732-738.

10.Ferry JA, Harris NL, Papanicolaou N, Young RH. Lymphoma of the kidney. A report of 11 cases. Am J Surg Pathol 1995;19:134-144.

11.Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathological study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994;18:376-390.

12. D. Nasioudis, P. N. Kampaktsis, M. Frey, S. S. Witkin, and K. Holcomb. “Primary lymphoma of the female genital tract: an analysis of 697cases. 2017: GynecologicOncology,vol.145,no.2,pp. 305–309.

13.Bhartiya R, Kumari N, Mallik M, Singh RV. Primary non Hodgkin's lymphoma of the ovary - a case report. J Clin Diagn Res. 2016;10(5):ED10-1.

14.Seidler SJ, Lovey PY, Busuioc CI, Huber DE. Gynaecoogical lymphomas: case reports and literature review of primary extranodal female genital tract and breast non hodgkin lymphomas. Archives in Cancer Research. ISSN 2254-6081; 6(4):20

15.Okuno SH, Hoyer JD, Ristow K, Witzig TE. Primary renal non-Hodgkin’s lymphoma. An unusual extranodal site. Cancer. 1995; 75: 2258–2261.

16.Moretti L, Medeiros LJ, Kunkalla K, Williams MD, Singh RR, Vega F. N- terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas. Mod Pathol.2012;25(2):231-236

17.Al-Maghrabi J, Kamal- Reid S, Jewett M, Gospodarowicz, W Wells, D Banerjee. Primary low grade B cell lymphoma of mucosa-associated lymphoid tissue type arising in the urinary bladder:report of 4 cases with molecular genetic analysis.Arch Pathol Lab Med 2001;125:332-336

18.Cohen DD, Lamarre C, Lamarre L. Primary low gradeB-cell lymphoma of the urinary bladder: case report and literature review. Can J Urol 2002;9:1694-1697.

19.Kim HY, Oh SY, Lee S, Kim SH, Kwon HC, Hong HC, et al. Primary penile diffuse large B cell lymphoma treated by local excision followed by rituximab-containing chemotherapy. Acta Haematol 2008;120:150-152

20.Lo HC, Yu DS, Lee CT, Chen A, Sun GH. Primary B cell lymphoma of the penis: successful treatment with organ preservation. Arch Androl 2003;49:467-470

21.Wei CC, Peng CT, Chiang IP, Wu KH. Primary B cell non- Hodgkin lymphoma of the penis in a child. J Pediatr Hematol Oncol 2006;28;479-480.

22.Merino de Paz N, Rodríguez-Martín M, Contreras Ferrer P, García-Hernández S, Hernández-León N, Martín-Herrera A, Noda-Cabrera A. Cutaneous lesions as presentation form of mantle cell lymphoma. Dermatol Reports. 2011 Dec 6;3(3):e51. doi: 10.4081/dr.2011.e51. PMID: 25386303; PMCID: PMC4211511.

23.Vang R, Medeiros LJ, Silva EG, Gershenson DM, Deavers M. Non-Hodgkin’s lymphoma involving the vagina: a clinicopathologic analysis of 14 patients. Am J Surg Pathol. 2000;24(5):719-725.

24. Phillips SM, Ferry DR, Lee SJ. Carcinoma of the prostatemimicking lymphoma. Br J Urol 1994;73:590 –1

25.Patel DR, Gomez GA, Henderson ES, Gamarra M. Primaryprostatic involvement in non-Hodgkin lymphoma. Urology1988;32:96 – 8.

26.George J. et al, The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors,European Urology,Volume 82, Issue 5, 2022, Pages 469-482

27.D.G. Bostwick, K.A. Iczkowski, M.B. Amin, G. Discigil, B. Osborne. Malignant lymphoma involving the prostate: report of 62 cases.Cancer, 83 (4) (1998), pp. 732-73

28.Kubots Y, Kawai A, Tsuchiya T, Kozima K, Yokoi S, Deguchi T. Bilateral primary malignant lymphoma of the ureter. Int J Clin Oncol. 2007;12:482-484.

29. Farid K, Yahya D, Reza P, Matias K, Heinrich WH. Lymphomas of the female genital tract: A study of 186 cases and review of the literature. Am J Surg Pathol. 2005;29(11):1512-1520.

Downloads

Published

29-10-2025

How to Cite

1.
Soni V, Gandhi J, Kakoty S, Shah AH, Trivedi P. Malignant Lymphomas of the Genitourinary Tract: a Single Center Study in Western India. Ann of Pathol and Lab Med [Internet]. 2025 Oct. 29 [cited 2025 Dec. 5];12(10):A329-A335. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3618

Issue

Section

Original Article